- Compugen (CGEN -20.5%) plunges after pricing its public offering of 6M shares at $10.50/share, a discount of 26% to yesterday's $14.20 closing price.
- Compugen shares ended last week at $11.60 but surged this week to challenge decade highs; the Israel-based biotech will raise nearly $60M in the offering, but at a punishing price to y new shareholders who bought into this week’s strength.
From other sites
at Zacks.com (Feb 27, 2015)
at CNBC.com (Feb 25, 2014)
at CNBC.com (Sep 3, 2013)
at MarketWatch.com (Aug 5, 2013)
at MarketWatch.com (May 19, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs